Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
PHASE3
This phase III trial compares immunotherapy drugs (nivolumab or brentuximab...
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
PHASE2
This phase II trial studies the side effects and how well combination chemo...
Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
PHASE2
This phase II trial tests the effect of dose-adjusted etoposide, prednisone...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
PHASE2
This clinical trial studies combination chemotherapy, radiation therapy, an...